Liron Caplan
M.D.
Assistant Professor of Medicine

Medical School:  1995-1999 Baylor College of Medicine, Houston, Texas

Postgraduate training:

When arrived at UCD: 2005

Past and current professional positions:

1994-1995 Research Assistant, Dept. of Cellular Biology, University of Texas Medical School Houston , TX

2003-2005 Hospitalist, Gold Medical Service, Barnes-Jewish Hospital, St. Louis, MO

2005-present Assistant Professor of Medicine/Rheumatology, University of Colorado Denver, Denver, CO

2006-present Affiliate Investigator, Colorado Research Enhancement Award Program to Improve Care for Veterans. Denver, CO

2006-present Electronic Health Record Implemenation Coordinator, Division of Rheumatology, University of Colorado Hospital, Denver, CO

Awards and Honors received:

National Institutes of Health Rheumatology Training Grant (T32), 2003, 2004.

Centocor Health Outcomes in Rheumatic Diseases (CHORD) Fellowship Grant, 2003

NYU Advanced Seminar in Rheumatology Travel Award Scholarship, 2004

American College of Rheumatology Fellow Award, 2004

American College of Rheumatology Research and Education Foundation Clinical Investigator Fellowship Award, 2005

Research Interests:

Dr. Caplan is a rheumatologist and Staff Physician at the University of Colorado Hospital as well as the Denver Veterans Affairs Medical Center. He is currently pursuing a doctoral degree in Clinical Science/Health Services Research and the University of Colorado.  Dr. Caplan engages in clinically-oriented epidemiologic and health service research within the field of pharmacoepidemiology and autoimmunity/rheumatology.  Areas of interest include retrospective analysis of databases, as well as prospective data collection and analysis.  Dr. Caplan’s has worked with the National Data Bank for Rheumatic Diseases, focusing on the pharmacoepidemiology of steroids in patients with Rheumatoid Arthritis (RA), as well as pulmonary complications of RA and its treatment.

Representative Publications:

Elami A, Caplan L, Rudis E. How do you spell 21 mm? Eur J Cardiothorac Surg. 1999;16(2):253-254.

Hron J, Caplan L(Co-first author), Gerth A, Schwartzberg P, Peng S. SH2D1A regulates T-dependent humoral autoimmunity. J Exp Med 2004; 200(2):261-266.

Wolfe F, Caplan L, Michaud K. Measuring the Efficacy and Effectiveness of RA therapy: Time to Change our Thinking and Adopt a New Model. [Editorial]. J Rheum. 2004; 31(12):2317-2319.

Caplan L , Russell AS. Wolfe F. Steroids for rheumatoid arthritis: the honeymoon revisited (once again). [Editorial]. J Rheum. 2005; 32(10):1863-1865.

Wolfe F, Caplan L, Michaud K. Treatment for Rheumatoid Arthritis and the Risk of Hospitalization for Pneumonia: Associations with Prednisone, Disease Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Therapy. Arthritis Rheum 2006;54(2):628-634.

Wolfe F, Caplan L, Michaud K. Rheumatoid Arthritis Treatment and the Risk of Severe Interstitial Lung Disease. Scand J Rheum (accepted for publication) 2007

Caplan L , Wolfe F, Michaud K. Prednisone use in rheumatoid arthritis: Prevalence, predictors, correlates and outcomes. J Rheumatol 2007;34:696-705.

Caplan L , Wolfe F, Michaud K. Prednisone Use and the Risk of Cataract Formation in Persons with Rheumatoid Arthritis, (Manuscript in preparation), 2007.